SCHEDULE
Program Schedule
| Time | Activity | |
|---|---|---|
| 08:30 – 10:30am | Opening Ceremony | |
| 10:30am – 12:00pm | Exhibition and Coffee Break | |
| 12:00pm – 2:00pm | Workshop 1 Oriental 2 | Utilizing Antibiotic Use Data to Strengthen Antimicrobial Stewardship: Evaluation and Identification of Targets Dr. Mamoon Aldeyab Director- International Clinical Practice Research Unit (ICPRU), University of Huddersfield/UK |
| 12:00pm – 2:00pm | Workshop 2 Mandarin II | Excellence in Community Pharmacy Practice: Focus on Medication Therapy Management (MTM) Dr. Ravi Sharma Group Chief Pharmacy Officer, Burjeel Holdings, UAE |
| 12:00pm – 2:00pm | Workshop 3 The Chairman Boardroom | Steps of Conducting Effective Clinical Audits: From Planning to Implementation Dr. Saleh Sudan Al Ghamdi Performance Excellence Lead at MoH-KSA & Dr. Abdulateef S. Alokifi Quality, Leadership and Accreditation Advisor, General Director of Organizational Excellence, MoH, KSA |
| 12:00pm – 2:00pm | Workshop 4 Mandarin 1 | Anti Coagulation Stewardship Workshop Dr. Sara Al Balushi Director, Pharmaceutical Care Directorate, DGMS, MoH, Oman & Dr. Fakhr Z AlAyoubi President of Cardiology Clinic Pharmacist at the Saudi Heart Association, Intensivist Cardiology Clinic Pharmacist, King Khalid University Hospital, King Saud University Medical City, KSA |
| 12:00pm – 2:00pm | Workshop 5 Al Thuraya II & III | Medication Safety in High-Risk Situation Dr. Alpana Mair Head of Effective Prescribing and Therapeutics at the Scottish Government, Associate Professor, Edinburgh Napier University, UK |
| 02:00pm – 03:00pm | Lunch | |
| Schedule | |||
|---|---|---|---|
| 07:30-08:30am | Registration | ||
| Economic Burden of Diseases on Healthcare System Al Thuraya II & III Moderator: Dr. Ahmed Fassih | |||
| 08:30-08:50am | Novel Financing & Early Access Strategies for Rare Diseases & Orphan Drugs Prof. Ahmed Hamdan Aljedai Founding President of the Saudi Society of Clinical Pharmacy, Professor at AlFaisal University, KSA | ||
| 08:50-09:10am | Appropriate Polypharmacy – Sustainable Solutions to Address the Public Health and Economic Burden Dr. Alpana Mair Head of Effective Prescribing and Therapeutics at the Scottish Government, Associate Professor, Edinburgh Napier University, UK | ||
| 09:10-09:30am | The Impact of Obesity on Healthcare Dr. Amira Al Kharusi Consultant Bariatric Physician, National Diabetes & Endocrine Centre, Royal Hospital, Oman | ||
| 09:30-09:50am | Nutrition & Disease Burden: The Economic Impact of Parenteral Nutrition Therapy Dr. Osama Tabbara President, IVPN-Network, Pharmacy Consultant | ||
| 09:50-10:00am | Discussion | ||
| 10:00-11:00am | Coffee Break & Exhibition | ||
| Parallel Session | |||
| Clinical pharmacy & Value-Based Care Al Thuraya II & III Moderator: Dr. Fatma Al Raisi | Advancement in Pharmacy Education & Practice Mandarin I & II Moderator: Prof. Ahmed Awaisu | ||
| 11:00-11:15am | Clinical and Economical Value of Clinical Pharmacist Interventions in Cancer Care Dr. Anas Hamad Director of Pharmacy Department, National Center for Cancer Care & Research, Hamad Medical Corporation, Clinical Associate Professor, College of Pharmacy, Qatar University, Qatar | Live Invertebrate Models in Toxicology and Drug Delivery Prof. Vitaliy Khutoryaniskiy Professor of Formulation Science at University of Reading, UK | |
| 11:15-11:30am | Oral Magnesium Supplements and Type 2 Diabetes Mellitus Control: PILOT Results from Phase-Three Follow-Up Period of a Double-Blind Randomized Control Trial Dr. Juhaina Salim Al-Maqbali Senior Specialist Pharmacist at the Department of Pharmacy, Sultan Qaboos University Hospital, University Medical City, Oman | Interprofessional Education: Driving Excellence in Pharmacy Practice and Catalyzing Collaborative Practice – Success Stories from Qatar and the Arab World Dr. Alla El-Awaisi Advisor to the Vice President for Health and Medical Sciences & Section Head of the Interprofessional Education Program, Qatar University, Qatar | |
| 11:30-11:45am | Impact of Dapagliflozin on Blood Pressure in Omani Patients with Type-2 Diabetes: A Prospective Single-Center Study Dr. Amna AL-Alawi Clinical Pharmacist, Diwan Poly Clinic, Oman | Beyond Grades: The Transformative Impact of Ajman University’s Student Success Centre on Academic Excellence & Leadership Development Dr. Nadir Kheir Professor of Pharmacy Practice and Manager of the Student Success Center at Ajman University, UAE | |
| 11:45am-12:00pm | From Audit to Action: Transforming Medication Error Trends to Derive System Improvements Dr. Amani Al Shaban Group Manager Pharmaceutical Care Standardization & Optimization, Eastern Healthcare Cluster, Senior Pharmacist, KSA | Team Based Learning (TBL) in Pharmacy Education: Enhancing Therapeutic Competency through Collaboration Dr. Raya Al Maskari Assistant Professor, Department of Pharmacology & Clinical Pharmacy, College of Medicine and Health Sciences, SQU, Oman | |
| 12:00-12:30pm | Panel Discussion | ||
| Value Based Healthcare Mandarin I & II Moderator: Dr. Ibrahim Al Khars | Stewardship Programs in Enhancing Patient Related Outcomes Al Thuraya II & III Moderator: Thamna Al Shibani | ||
| 12:30-12:45pm | Awareness, Knowledge and Attitudes of Health-Care Providers Regarding Pharmacoeconomics in Oman Dr. Shireen Al-Zadjali National Hematology and Bone Marrow Transplant Centre, University Medical City, Oman | Balancing Relief & Responsibility: Optimizing Opioid Use Through Stewardship Dr. Saeed Hussein Head of Pharmacy, Erada Centre for Treatment & Rehab, Dubai, UAE | |
| 12:45-13:00pm | MCDA Tool: The Way to More Fairness & Transparency Dr. Gihan El Sisi Managing Director, HTA Office, Middle East & North Africa, Assistant Professor in Health Economics, American University, Cairo | Assessing How to Select the Proper Anticoagulation for Inpatients, Including Safety & Efficacy Dr. Fakhr Z AlAyoubi President of Cardiology Clinic Pharmacist at the Saudi Heart Association, Intensivist Cardiology Clinic Pharmacist, King Khalid University Hospital, King Saud University Medical City, KSA | |
| 13:00-13:15pm | From Data to Insight: The Impact of Real-World Evidence in Healthcare Dr. Ibtisam Al-Harbi Head of Pharmacoeconomic Centre & Inpatient /IV Oncology Pharmaceutical Services at King Fahd Armed Forces Hospital, Jeddah, KSA | Evaluate the Bacterial Resistance Pattern in Northern Oman after Implementing Evidence Based Antimicrobial Stewardship Program: Five Years of Success Dr. Ahmed Al Zaabi Senior Specialized Pharmacist, Sohar Hospital, Oman | |
| 13:15-13:30pm | The Clinical and Economic Impact of a Specialist Nutrition Support Pharmacist in Optimising Total Parenteral Nutrition Use at Sultan Qaboos University Hospital Dr. Mohammed Adel Specialist Pharmacist, Aseptic Pharmacy Services at Medical University City (SQUH), Oman | Anticancer Stewardship: Applications in Hematological Malignancies Dr. Bushra Mustafa Al Lawati Senior Specialist Pharmacist, Omani National Hematology and Bone Marrow Transplant Center, University Medical City, Oman | |
| 13:30-13:45pm | Pfizer Symposium New Treatment Paradigm in Migraine Management – A Single Medication to Both Treat and Prevent Migraine: What is the Evidence? Dr. Osama Tabbara President, IVPN-Network, Pharmacy Consultant | Astra Zeneca Symposium Innovative Oncology: Evaluating Enhertu’s Clinical and Economic Benefits Dr. Anas Hamad Director of Pharmacy Department, National Center for Cancer Care & Research, Hamad Medical Corporation, Clinical Associate Professor, College of Pharmacy, Qatar University, Qatar | |
| 13:45-14:00pm | |||
| 14:00-15:00pm | |||
| 15:00-15:15pm | Novartis Symposium Role of Leqvio in Management of Dyslipidemia Prof. Khalid AlRasadi Professor Biochemistry, College of Medicine & Health Sciences, Consultant Lipidologist, Sultan Qaboos University Hospital, Director of Medical Research Centre, Sultan Qaboos University, Oman | ||
| 07:30-8:30am | Registration | ||
| Clinical Audit in Advancing Quality & Safety in Healthcare Services Al Thuraya II & III Moderator: Dr. Amna Al Hashar | |||
|---|---|---|---|
| 08:30-08:50am | Leveraging Data from Clinical Audit to Redefine Healthcare Best Practices Dr. Abdulateef S. Alokifi General Director of Organizational Excellence, MoH, KSA | ||
| 08:50-09:10am | ISMP Targeted Medication Safety Best Practices for Hospitals Dr. Dalia Saleh Alghamdi Head of Quality Policies and Standards Development Unit Clinical Excellence Department, Ministry of Defense Health Services, KSA | ||
| 09:10-09:30am | The Role of Clinical Audits in Preventing Medical Errors and Enhancing Patient Safety Dr. Jennifer Kozaily Director of Risk Management, American Hospital Dubai, UAE | ||
| 09:30-09:50am | Lesson Learned from Implementation of Pilot National Clinical Audits on Four Urgent Care Conditions in MoH Hospitals, KSA Dr. Saleh Sudan Al Ghamdi Performance Excellence Lead at MoH, KSA | ||
| 09:50-10:00am | Discussion | ||
| 10:00-11:00am | Coffee Break & Exhibition | ||
| Parallel Session | |||
| Building the Foundation for HTA in Middle East: Opportunities & Challenges Mandarin I & II Moderator: Prof. Ahmed Awaisu | Clinical Audits and Effective Patient Care Al Thuraya II & III Moderator: Dr. Fatma Al Ghfeli | ||
| 11:00-11:15am | Maximizing Value, Minimizing Disparities through VBHC Dr. Hajer Almudaiheem Drug Policy and Regulation Director, Therapeutic Affairs, MOH, KSA | Strengthening Clinical Governance: The Role of Clinical Audits in Ensuring High Quality Patient Care Dr. Saleh Sudan Al Ghamdi Performance Excellence Lead at MoH, KSA | |
| 11:15-11:30am | Methodological Guidelines for Health Technology Assessment in Oman Dr. Said Al Rashdi Health Economist, DGMS, Oman | Bridging the Gap: Using Clinical Audit to Align Practice with Guidelines Dr. Jennifer Kozaily Director of Risk Management, American Hospital, Dubai, UAE | |
| 11:30-11:45am | Hospital-Based HTA Program (KHCC) Dr. Abeer Al Rabayah Head of Centre for Drug Policy & Technology Assessment, King Hussien Cancer Centre, Jordan | Clinical Audit of Medicine Experience within MoH, Oman Dr. Suha AL Lawati Consultant Clinical Pharmacist, Directorate of Pharmaceutical Care, DGMS, MoH, Oman | |
| 11:45-12:00pm | Astra Zeneca Symposium Redefine Asthma Rescue Therapy Dr. Yaqoub AlMahruqi Senior Consultant, Pulmonologist, Royal Hospital, Oman | Therapeutic Drug Monitoring of Amikacin Among Hospitalized Patients in Oman Dr. Tiba Makki Clinical Pharmacist, Oman | |
| 12:00-12:15pm | Pfizer Symposium Role of Abrocitinib for the Management of Moderate to Severe Atopic Dermatitis TBA | Abbott Symposium The Next Generation of Human Milk Oligosaccharides Dima Bader Sr. Regional Medical Manager-MEAP | |
| 12:15-13:30pm | Panel Discussion | ||
| International Standards and Best Practices in Medication Safety Mandarin I & II Moderator: Dr. Fatma Al Ghfeli | Integration of AI in Pharmacy Al Thuraya II & III Moderator: Dr. Ravi Sharma | ||
| 13:00-13:15pm | General Overview of Changes in the JCI 8th Edition Related to Medication Management Dr. Dalia Saleh Al Ghamdi Head of Quality Policies and Standards Development Unit Clinical Excellence, Department Ministry of Defense, Health Services, KSA | AI in Health Economics and HTA: Opportunities, Challenges and Future Direction Dr. Abeer Al Rabayah Head of Centre for Drug Policy & Technology Assessment, King Hussien Cancer Centre, Jordan | |
| 13:15-13:30pm | From Risk to Safety: Implementation of Safe Medication Prescribing Program for Pediatrics as a High-Risk Population Dr. Zainab AL Zuhair Pediatric Allergy Immunology Clinical Pharmacist, Medication Safety Specialist, Adjunct Assistant Professor at Al Faisal University, KSA | Harnessing Data-Driven Innovation: A Case Study on Transforming Pharmacy Practice Dr. Ibrahim Al Khars General Manager, Governance, Compliance & Investor Relations, Innovest Company, Co-founder & Head of the Scientific Board, Afaq Health Education, KSA | |
| 13:30-13:45pm | Trends in Pharmacist-Led Medication Reconciliation Compliance at SQCCCRC: A Retrospective Review (2022–2024) Dr. Hayam Al Balushi Clinical Pharmacist, Sultan Qaboos Comprehensive Cancer Care and Research Center, Oman | Digital Health & AI: The Potential Impact on Pharmacy Practice Dr. Ravi Sharma Group Director of Pharmacy Services, Burjeel Holdings, UAE | |
| 13:45-14:00pm | Discussion | ||
| 14:00pm | Lunch | ||
LATEST NEWS
Final Preparations
Registration is Open
Early Bird Registration is Open
Quick Links
Ministry of Health
DGMS
Contact Us